All Stories

  1. Safety and tolerability of intrathecal liposomal amphotericin B (AmBisome) for cryptococcal meningitis: a retrospective study in HIV-infected patients
  2. Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
  3. Trends and factors associated with antimicrobial resistance of Acinetobacter spp. from invasive isolates in Europe: a country level analysis
  4. Differences in rpoB , katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDR plus assay
  5. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae
  6. Sex differences and factors influencing the duration of the QT interval in patients on anti-tuberculosis therapy
  7. Acute undifferentiated fever in India: a multicentre study of aetiology and diagnostic accuracy
  8. Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016
  9. Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India
  10. Poverty and prevalence of antimicrobial resistance in invasive isolates
  11. A High Malaria Prevalence Identified by PCR among Patients with Acute Undifferentiated Fever in India
  12. An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype
  13. Mortality in HIV-infected patients with tuberculosis treated with streptomycin and a two-week intensified regimen: data from an HIV cohort study using inverse probability of treatment weighting
  14. Hair dye poisoning: Retrospective analyses of patients admitted to ICU at a rural hospital in India
  15. Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients
  16. Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis
  17. Induction with Lopinavir-Based Treatment Followed by Switch to Nevirapine-Based Regimen versus Non-Nucleoside Reverse Transcriptase Inhibitors-Based Treatment for First Line Antiretroviral Therapy in HIV Infected Children Three Years and Older
  18. High prescription of antimicrobials in a rural district hospital in India
  19. Mortality and loss to follow up before initiation of antiretroviral therapy among HIV-infected children eligible for HIV treatment
  20. Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India
  21. Predictors of loss to follow-up after engagement in care of HIV-infected children ineligible for antiretroviral therapy in an HIV cohort study in India
  22. Development of pharmacoeconomics guidelines
  23. Prevalence and Severity of Anaemia Stratified by Age and Gender in Rural India
  24. Cost-Analysis of the WHO Essential Medicines List in A Resource-Limited Setting: Experience From A District Hospital in India
  25. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India
  26. Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines
  27. Factors associated with loss to follow up after entry into care of HIV infected children ineligible for antiretroviral therapy: data from an HIV cohort study in India
  28. Directly-Observed Intermittent Therapy versus Unsupervised Daily Regimen during the Intensive Phase of Antituberculosis Therapy in HIV Infected Patients
  29. An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes
  30. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India
  31. Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India
  32. ABC Analysis Of Pharmaceuticals In A Resource Limited Rural Hospital In India
  33. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings
  34. Intra-Abscess Administration of Antibiotics Through Ultrasound–Guided Percutaneous Catheter for the Treatment of Pyogenic Liver Abscess
  35. Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries
  36. Initial Antituberculous Regimen with Better Drug Penetration into Cerebrospinal Fluid Reduces Mortality in HIV Infected Patients with Tuberculous Meningitis: Data from an HIV Observational Cohort Study
  37. Predictors of Attrition in Patients Ineligible for Antiretroviral Therapy after Being Diagnosed with HIV: Data from an HIV Cohort Study in India
  38. Predictors of Delayed Antiretroviral Therapy Initiation, Mortality, and Loss to Followup in HIV Infected Patients Eligible for HIV Treatment: Data from an HIV Cohort Study in India
  39. Predictors of Delayed Entry into Medical Care of Children Diagnosed with HIV Infection: Data from an HIV Cohort Study in India
  40. An interventional study on intensive care unit drug therapy assessment in a rural district hospital in India
  41. Gender differences in health related quality of life of people living with HIV/AIDS in the era of highly active antiretroviral therapy
  42. Potential Impact of a Free Online HIV Treatment Response Prediction System for Reducing Virological Failures and Drug Costs after Antiretroviral Therapy Failure in a Resource-Limited Setting
  43. Multi-professionalism for medical education in developing countries
  44. Computational models that predict response to HIV therapy can reduce virological failure and therapy costs in resource-limited settings
  45. PHP44 Implementation & Evaluation of Essential Medicines List 2011 in a Rural Resource Limited District Hospital in India
  46. Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting
  47. Point of care testing of HIV in children younger than 18 months with three different HIV virological assays. Experience from a district hospital in a resource-limited setting
  48. Early HIV viral load determination after initiating first-line antiretroviral therapy for indentifying patients with high risk of developing virological failure: data from a cohort study in a resource-limited setting
  49. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India
  50. Socio-demographic risk factors associated with HIV infection in patients seeking medical advice in a rural hospital of India
  51. Trends and risk factors for HIV infection among young pregnant women in rural India
  52. False negative HIV antibody test in HIV infected children who receive early antiretroviral treatment in a resource-limited setting
  53. Essential medicines concept for quality assurance of health care facilities
  54. Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India
  55. Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India
  56. Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India
  57. Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study ...
  58. Prevalence and Antibiotic Susceptibility of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Rural Area of India: Is MRSA Replacing Methicillin-Susceptible Staphylococcus aureus in the Community?
  59. Evaluation of a Low-Cost Strategy for Enumerating CD4 Lymphocyte Absolute Count and Percentage Using the FACSCalibur Flow Cytometer in HIV-Infected Patients from a Resource-Limited Setting
  60. Early syphilis mimicking tuberculous meningoencephalitis in an HIV-positive patient
  61. Lung disease caused by nontuberculous mycobacteria
  62. Reduction in Neutrophil Count During Hepatitis C Treatment: Drug Toxicity or Predictor of Good Response?
  63. Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection
  64. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort
  65. Non-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization?
  66. Herpetic tracheitis and polybacterial pneumonia in an immunocompetent young man
  67. Hemorragia masiva por hiperplasia nodular de glándulas de Brunner en el síndrome antifosfolipídico
  68. Hemorragia masiva por hiperplasia nodular de glándulas de Brunner en el síndrome antifosfolipídico
  69. Síndrome HELLP asociado a embolia pulmonar y factor V de Leiden
  70. La imagen de la semana